CAS: 3034-22-8; 5-Bromothiazol-2-Amine

该化合物是一种有机化合物,其特点是硫化环,即五人组成的含有硫和氮原子的环环环结构.在2点和5点存在一个氨基组(-NH2),5点存在一个溴原子,有助于其反应和在各种化学反应中的潜在应用.该化合物一般是固体,在极地溶剂中溶解.它以生物活动著称,它具有医学化学意义,特别是在药品开发方面.硫酸盐的细胞常与多种生物特性有关,包括抗微生物和抗硫酸盐活动.此外,2-氨基-5-溴-甲诺尔可以参与各种合成变异,作为复杂分子的建筑块.安全数据表明,与许多溴化化合物一样,它应该受到潜在毒性和环境关切的注意.

结构式图片

上下游产品

CAS号61296-22-8 2-氨基-5-溴噻唑氢溴酸盐 | CAS号96-50-4 2-氨基噻唑 | CAS号7336-54-1 2-乙酰氨基-5-溴-1,3-噻唑 | CAS号3034-56-8 5-溴-2-氯噻唑 | CAS号226879-69-2 Carbamic acid,N... | CAS号405939-39-1 N-B°C-2-氨基-5-溴噻唑 | CAS号4175-78-4 2,5-二溴噻唑 | CAS号96-50-4 2-氨基噻唑 | CAS号3034-55-7 5-溴噻唑 | CAS号859522-19-3 2-(2-氨基噻唑-5-硫基)乙酸乙酯 | CAS号7336-54-1 2-乙酰氨基-5-溴-1,3-噻唑 | CAS号745053-65-0 N-(5-溴-1,3-噻唑-2... | CAS号840493-96-1 N-(5-BROMOTHIAZ... | CAS号918792-84-4 5-bromo-2-(2,5-... | CAS号944581-13-9 2-bromo-6-(4-ni...

合成工艺路线路线简述

  • 合成目标产物 2-Amino-5-Bromothiazole 主要起始原料 2-Aminothiazole
  • (文献来源)合成步骤主要原料 2-Aminothiazole
2-氨基噻唑置于n-溴代丁二酰亚胺(Nbs)体系中,用 溶剂黄146 用作溶剂,化学反应生成2-氨基-5-溴噻唑
参考文献:顺序溴化-脱溴方法合成溴化噻唑
标题:顺序溴化-脱溴方法合成溴化噻唑
摘要:溴噻唑全家族的合成已被重新研究,以更新和优化其生产.报告的物种包括2-溴噻唑,4-溴噻唑,5-溴噻唑,2,4-二溴噻唑,2,5-二溴噻唑,4,5-二溴噻唑和2,4,5-三溴噻唑,其中大多数是通过依次进行溴化和脱溴步骤.现在可以在不使用元素溴的情况下生产该完整家族,并且所提出的方法已允许首次报道该完整家族的物理和NMR光谱表征.
Doi:10.1021/acs.Joc.7B00495

专利信息


专利号:US-2025129021-A1
优先权日:2023-09-19
标 题:Small molecule protein synthesis modulators
发明人:GYGI DAVID; BAHMANYAR SOGOLE SAMI; HAMANN LAWRENCE
权利人:INTERDICT BIO INC
摘要:The present disclosure provides compounds of the formulae herein (e.g., Formula (I), Formula (V)), and pharmaceutically acceptable salts thereof, which are useful for modulating protein synthesis (e.g., modulating synthesis of BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D). The present disclosure also provides pharmaceutical compositions and kits comprising the compounds, or pharmaceutically acceptable salts thereof, and methods of treating or preventing diseases or disorders (e.g., diseases or disorders associated with BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D) by administering to a subject in need thereof the compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof.

专利号:US-6531470-B1
优先权日:1998-01-23
标题:Oxazolidinone combinatorial libraries, compositions and methods of preparation
发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V; NI ZHI-JIE; GORDON ERIC
权利人:UPJOHN CO
摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.

专利号:US-6562844-B2
优先权日:1998-01-23
标 题:Oxazolidinone combinatorial libraries, compositions and methods of preparation
发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V; NI ZHI-JIE; GORDON ERIC
权利人:UPJOHN CO
摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.

专利号:US-7002020-B1
优先权日:1998-01-23
标题:Oxazolidinone combinatorial libraries, compositions and methods of preparation
发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V
权利人:UPJOHN CO
摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.

专利号:CN-115785022-B
优先权日:2022-12-05
标 题:Synthesis of 2-amino-5-bromo-1,3,4-thiazole, an intermediate of cationic blue 159

专利号:CN-115785022-A
优先权日:2022-12-05
标题 :Synthesis of Cationic Blue 159 Intermediate 2-amino-5-bromo-1,3,4-thiazole
上海常丰生物医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.chainpharm.com
企业联系电话:021-61727342👤
📞上海常丰生物医药科技有限公司 ⚠️参考联系方式
联系人:张经理
电话:021-61727342
手机:13611721451
传真:021-33275302
邮箱:sales@chainpharm.com
通信地址: 上海金山区金瓯路188号
邮编: 201512
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海金山区金瓯路188号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海易信生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.bioyeexin.com
电话: 021-54176788 13671761800👤
📞上海易信生物科技有限公司 ⚠️参考联系方式

销售电话:021-54176788 13671761800
邮箱:sales@bioyeexin.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市水清路999弄61号602室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Koutentis, P. A.; Ioannidou, H. A., Science of Synthesis Knowledge Updates, (2010) 1, 362.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知